MedTrace Logo

Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

NCT00770406 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-08-04

No results posted yet for this study

Summary

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.

Conditions

  • Urge Urinary Incontinence

Interventions

DRUG

botulinum toxin type A

100 or 200 units intravesically

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00770406 on ClinicalTrials.gov